MediPharm Labs Corp. (MEDIF)
OTCMKTS · Delayed Price · Currency is USD
0.0577
-0.0002 (-0.42%)
Oct 13, 2025, 3:19 PM EDT
MediPharm Labs Revenue
MediPharm Labs had revenue of 11.81M CAD in the quarter ending June 30, 2025, with 14.09% growth. This brings the company's revenue in the last twelve months to 44.45M, up 17.74% year-over-year. In the year 2024, MediPharm Labs had annual revenue of 41.96M with 26.92% growth.
Revenue (ttm)
44.45M CAD
Revenue Growth
+17.74%
P/S Ratio
0.74
Revenue / Employee
276.11K CAD
Employees
161
Market Cap
24.05M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 41.96M | 8.90M | 26.92% |
Dec 31, 2023 | 33.06M | 10.94M | 49.49% |
Dec 31, 2022 | 22.12M | 406.00K | 1.87% |
Dec 31, 2021 | 21.71M | -14.30M | -39.71% |
Dec 31, 2020 | 36.01M | -93.24M | -72.14% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Elite Pharmaceuticals | 105.45M |
Glass House Brands | 221.55M |
Veradigm | 588.02M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
Jushi Holdings | 256.36M |
Nuo Therapeutics | 1.95M |
MediPharm Labs News
- 2 months ago - MediPharm Strengthens Global Position in Q2 2025, with 14% Revenue Growth and 50% Increase in International Medical Cannabis - GlobeNewsWire
- 2 months ago - MediPharm Labs Positioned for Unique Opportunities on Possible Rescheduling of Cannabis in the United States - PRNewsWire
- 2 months ago - MediPharm Labs Sets Date to Report Second Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - MediPharm Labs Expands Leading CBN Oil Portfolio with The Launch of New Nighttime Inhaler - GlobeNewsWire
- 4 months ago - MediPharm Announces Voting Results from the 2025 Annual and Special Meeting of Shareholders - GlobeNewsWire
- 4 months ago - MediPharm Cautions Shareholders To Await Final Results of Annual and Special Meeting - GlobeNewsWire
- 4 months ago - Apollo Capital Wins Proxy Contest at MediPharm Labs - GlobeNewsWire
- 4 months ago - Leading Independent Proxy Advisor Glass Lewis Recommends Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees - GlobeNewsWire